Tapewire

Nasdaq · USD

APVO

Aptevo Therapeutics Inc.

Export transactions ↓
Tapewire entity
8337
SEC CIK
0001671584
Parsed reports
238

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 29, 2021 Filed Feb 18, 2021 02:01 UTC
Gross Jane ASVP & Chief Scientific Officer
GrantRestricted Stock Unit · Derivative 5,500 $0.00 $0.00
Disclosure

SEC source: 0001019056-21-000142 · gross.xml · derivative · entry 2

Gross Jane A · CIK 0001684258 · SVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,500

Underlying: Common Stock · 5,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Restricted stock units (the "RSUs") convert into shares of the Issuer's common stock on a one-for-one basis.

F3 · derivative.exercise_date: The RSU vests in three approximately equal annual installments beginning on January 29, 2022.

F3 · derivative.expiration_date: The RSU vests in three approximately equal annual installments beginning on January 29, 2022.

Read SEC document
January 29, 2021 Filed Feb 18, 2021 02:01 UTC
Gross Jane ASVP & Chief Scientific Officer
GrantStock Option (right to buy) · Derivative 16,500 $0.00 Strike: $33.50 $0.00
Disclosure

SEC source: 0001019056-21-000142 · gross.xml · derivative · entry 1

Gross Jane A · CIK 0001684258 · SVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 16,500 shares

Expires 2031-01-29

F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on January 29, 2022.

Read SEC document
January 29, 2021 Filed Feb 18, 2021 02:03 UTC
White Marvin LDirector · President and CEO
GrantRestricted Stock Unit · Derivative 14,375 $0.00 $0.00
Disclosure

SEC source: 0001019056-21-000147 · white.xml · derivative · entry 2

White Marvin L · CIK 0001493324 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,375

Underlying: Common Stock · 14,375 shares

Expires not disclosed

F2 · derivative.exercise_price: Restricted stock units (the "RSUs") convert into shares of the Issuer's common stock on a one-for-one basis.

F3 · derivative.exercise_date: The RSU vests in three approximately equal annual installments beginning on January 29, 2022.

F3 · derivative.expiration_date: The RSU vests in three approximately equal annual installments beginning on January 29, 2022.

Read SEC document
January 29, 2021 Filed Feb 18, 2021 02:03 UTC
White Marvin LDirector · President and CEO
GrantStock Option (right to buy) · Derivative 43,125 $0.00 Strike: $33.50 $0.00
Disclosure

SEC source: 0001019056-21-000147 · white.xml · derivative · entry 1

White Marvin L · CIK 0001493324 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,125

Underlying: Common Stock · 43,125 shares

Expires 2031-01-29

F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on January 29, 2022.

Read SEC document
January 29, 2021 Filed Feb 18, 2021 02:02 UTC GrantRestricted Stock Unit · Derivative 5,500 $0.00 $0.00
Disclosure

SEC source: 0001019056-21-000145 · lamothe.xml · derivative · entry 2

Lamothe Jeffrey G. · CIK 0001679967 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,500

Underlying: Common Stock · 5,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Restricted stock units (the "RSUs") convert into shares of the Issuer's common stock on a one-for-one basis.

F3 · derivative.exercise_date: The RSU vests in three approximately equal annual installments beginning on January 29, 2022.

F3 · derivative.expiration_date: The RSU vests in three approximately equal annual installments beginning on January 29, 2022.

Read SEC document
January 29, 2021 Filed Feb 18, 2021 02:02 UTC GrantStock Option (right to buy) · Derivative 16,500 $0.00 Strike: $33.50 $0.00
Disclosure

SEC source: 0001019056-21-000145 · lamothe.xml · derivative · entry 1

Lamothe Jeffrey G. · CIK 0001679967 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 16,500 shares

Expires 2031-01-29

F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on January 29, 2022.

Read SEC document
November 06, 2020 Filed Nov 6, 2020 21:47 UTC
TANG KEVIN10% owner
PurchaseCommon Stock 2,650 $23.87 $63,255.50
Disclosure

SEC source: 0001209191-20-057304 · doc4.xml · nonDerivative · entry 16

TANG KEVIN C · CIK 0001178579 · 10% owner

TANG CAPITAL MANAGEMENT LLC · CIK 0001232621 · 10% owner

TANG CAPITAL PARTNERS LP · CIK 0001191935 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 1,760,000

F17 · price: The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $23.85 to $23.87.

F2 · ownership.direct: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

F2 · ownership.nature: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Read SEC document
November 06, 2020 Filed Nov 6, 2020 21:47 UTC
TANG KEVIN10% owner
PurchaseCommon Stock 107,901 $23.48 $2,533,515.48
Disclosure

SEC source: 0001209191-20-057304 · doc4.xml · nonDerivative · entry 15

TANG KEVIN C · CIK 0001178579 · 10% owner

TANG CAPITAL MANAGEMENT LLC · CIK 0001232621 · 10% owner

TANG CAPITAL PARTNERS LP · CIK 0001191935 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 1,757,350

F16 · price: The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $22.85 to $23.84.

F2 · ownership.direct: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

F2 · ownership.nature: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Read SEC document
November 06, 2020 Filed Nov 6, 2020 21:47 UTC
TANG KEVIN10% owner
PurchaseCommon Stock 29,682 $22.33 $662,799.06
Disclosure

SEC source: 0001209191-20-057304 · doc4.xml · nonDerivative · entry 14

TANG KEVIN C · CIK 0001178579 · 10% owner

TANG CAPITAL MANAGEMENT LLC · CIK 0001232621 · 10% owner

TANG CAPITAL PARTNERS LP · CIK 0001191935 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 1,649,449

F15 · price: The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $21.85 to $22.84.

F2 · ownership.direct: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

F2 · ownership.nature: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Read SEC document
November 06, 2020 Filed Nov 6, 2020 21:47 UTC
TANG KEVIN10% owner
PurchaseCommon Stock 34,044 $20.63 $702,327.72
Disclosure

SEC source: 0001209191-20-057304 · doc4.xml · nonDerivative · entry 13

TANG KEVIN C · CIK 0001178579 · 10% owner

TANG CAPITAL MANAGEMENT LLC · CIK 0001232621 · 10% owner

TANG CAPITAL PARTNERS LP · CIK 0001191935 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 1,619,767

F14 · price: The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $20.10 to $21.00.

F2 · ownership.direct: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

F2 · ownership.nature: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Read SEC document
November 05, 2020 Filed Nov 6, 2020 21:47 UTC
TANG KEVIN10% owner
PurchaseCommon Stock 8,482 $20.94 $177,613.08
Disclosure

SEC source: 0001209191-20-057304 · doc4.xml · nonDerivative · entry 12

TANG KEVIN C · CIK 0001178579 · 10% owner

TANG CAPITAL MANAGEMENT LLC · CIK 0001232621 · 10% owner

TANG CAPITAL PARTNERS LP · CIK 0001191935 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 1,585,723

F13 · price: The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $20.86 to $21.00.

F2 · ownership.direct: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

F2 · ownership.nature: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Read SEC document
November 05, 2020 Filed Nov 6, 2020 21:47 UTC
TANG KEVIN10% owner
PurchaseCommon Stock 137,241 $20.78 $2,851,867.98
Disclosure

SEC source: 0001209191-20-057304 · doc4.xml · nonDerivative · entry 11

TANG KEVIN C · CIK 0001178579 · 10% owner

TANG CAPITAL MANAGEMENT LLC · CIK 0001232621 · 10% owner

TANG CAPITAL PARTNERS LP · CIK 0001191935 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 1,577,241

F12 · price: The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $20.18 to $21.00.

F2 · ownership.direct: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

F2 · ownership.nature: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Read SEC document
November 05, 2020 Filed Nov 6, 2020 21:47 UTC
TANG KEVIN10% owner
PurchaseCommon Stock 171,626 $23.79 $4,082,982.54
Disclosure

SEC source: 0001209191-20-057304 · doc4.xml · nonDerivative · entry 10

TANG KEVIN C · CIK 0001178579 · 10% owner

TANG CAPITAL MANAGEMENT LLC · CIK 0001232621 · 10% owner

TANG CAPITAL PARTNERS LP · CIK 0001191935 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 1,440,000

F11 · price: The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $23.09 to $24.00.

F2 · ownership.direct: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

F2 · ownership.nature: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Read SEC document
November 05, 2020 Filed Nov 6, 2020 21:47 UTC
TANG KEVIN10% owner
PurchaseCommon Stock 71,241 $15.32 $1,091,412.12
Disclosure

SEC source: 0001209191-20-057304 · doc4.xml · nonDerivative · entry 9

TANG KEVIN C · CIK 0001178579 · 10% owner

TANG CAPITAL MANAGEMENT LLC · CIK 0001232621 · 10% owner

TANG CAPITAL PARTNERS LP · CIK 0001191935 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 1,268,374

F10 · price: The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $14.98 to $15.50.

F2 · ownership.direct: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

F2 · ownership.nature: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Read SEC document
November 05, 2020 Filed Nov 6, 2020 21:47 UTC
TANG KEVIN10% owner
PurchaseCommon Stock 77,133 $14.22 $1,096,831.26
Disclosure

SEC source: 0001209191-20-057304 · doc4.xml · nonDerivative · entry 8

TANG KEVIN C · CIK 0001178579 · 10% owner

TANG CAPITAL MANAGEMENT LLC · CIK 0001232621 · 10% owner

TANG CAPITAL PARTNERS LP · CIK 0001191935 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 1,197,133

F9 · price: The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $13.98 to $14.93.

F2 · ownership.direct: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

F2 · ownership.nature: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Read SEC document
November 05, 2020 Filed Nov 6, 2020 21:47 UTC
TANG KEVIN10% owner
PurchaseCommon Stock 160,000 $15.31 $2,449,600.00
Disclosure

SEC source: 0001209191-20-057304 · doc4.xml · nonDerivative · entry 7

TANG KEVIN C · CIK 0001178579 · 10% owner

TANG CAPITAL MANAGEMENT LLC · CIK 0001232621 · 10% owner

TANG CAPITAL PARTNERS LP · CIK 0001191935 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 1,120,000

F8 · price: The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $14.74 to $15.50.

F2 · ownership.direct: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

F2 · ownership.nature: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Read SEC document
November 04, 2020 Filed Nov 6, 2020 21:47 UTC
TANG KEVIN10% owner
PurchaseCommon Stock 160,000 $16.84 $2,694,400.00
Disclosure

SEC source: 0001209191-20-057304 · doc4.xml · nonDerivative · entry 6

TANG KEVIN C · CIK 0001178579 · 10% owner

TANG CAPITAL MANAGEMENT LLC · CIK 0001232621 · 10% owner

TANG CAPITAL PARTNERS LP · CIK 0001191935 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 960,000

F7 · price: The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $16.33 to $17.00.

F2 · ownership.direct: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

F2 · ownership.nature: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Read SEC document
November 04, 2020 Filed Nov 6, 2020 21:47 UTC
TANG KEVIN10% owner
PurchaseCommon Stock 60,146 $16.33 $982,184.18
Disclosure

SEC source: 0001209191-20-057304 · doc4.xml · nonDerivative · entry 5

TANG KEVIN C · CIK 0001178579 · 10% owner

TANG CAPITAL MANAGEMENT LLC · CIK 0001232621 · 10% owner

TANG CAPITAL PARTNERS LP · CIK 0001191935 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 800,000

F6 · price: The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $16.18 to $16.45.

F2 · ownership.direct: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

F2 · ownership.nature: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Read SEC document
November 04, 2020 Filed Nov 6, 2020 21:47 UTC
TANG KEVIN10% owner
PurchaseCommon Stock 99,854 $13.65 $1,363,007.10
Disclosure

SEC source: 0001209191-20-057304 · doc4.xml · nonDerivative · entry 4

TANG KEVIN C · CIK 0001178579 · 10% owner

TANG CAPITAL MANAGEMENT LLC · CIK 0001232621 · 10% owner

TANG CAPITAL PARTNERS LP · CIK 0001191935 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 739,854

F5 · price: The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $13.18 to $14.00.

F2 · ownership.direct: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

F2 · ownership.nature: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Read SEC document
November 04, 2020 Filed Nov 6, 2020 21:47 UTC
TANG KEVIN10% owner
PurchaseCommon Stock 160,000 $13.83 $2,212,800.00
Disclosure

SEC source: 0001209191-20-057304 · doc4.xml · nonDerivative · entry 3

TANG KEVIN C · CIK 0001178579 · 10% owner

TANG CAPITAL MANAGEMENT LLC · CIK 0001232621 · 10% owner

TANG CAPITAL PARTNERS LP · CIK 0001191935 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 640,000

F4 · price: The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $13.33 to $14.00.

F2 · ownership.direct: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

F2 · ownership.nature: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Read SEC document
November 04, 2020 Filed Nov 6, 2020 21:47 UTC
TANG KEVIN10% owner
PurchaseCommon Stock 88,379 $13.11 $1,158,648.69
Disclosure

SEC source: 0001209191-20-057304 · doc4.xml · nonDerivative · entry 2

TANG KEVIN C · CIK 0001178579 · 10% owner

TANG CAPITAL MANAGEMENT LLC · CIK 0001232621 · 10% owner

TANG CAPITAL PARTNERS LP · CIK 0001191935 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 480,000

F3 · price: The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $12.88 to $13.44.

F2 · ownership.direct: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

F2 · ownership.nature: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Read SEC document
November 04, 2020 Filed Nov 6, 2020 21:47 UTC
TANG KEVIN10% owner
PurchaseCommon Stock 68,296 $10.63 $725,986.48
Disclosure

SEC source: 0001209191-20-057304 · doc4.xml · nonDerivative · entry 1

TANG KEVIN C · CIK 0001178579 · 10% owner

TANG CAPITAL MANAGEMENT LLC · CIK 0001232621 · 10% owner

TANG CAPITAL PARTNERS LP · CIK 0001191935 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 391,621

F1 · price: The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $10.11 to $11.00. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in footnotes 1 and 3 through 17 herein.

F2 · ownership.direct: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

F2 · ownership.nature: The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:50 UTC
Gross Jane ASVP & Chief Scientific Officer
GrantStock Option (right to buy) · Derivative 2,140 Not disclosed Strike: $8.56 Not disclosed
Disclosure

SEC source: 0001019056-20-000451 · gross.xml · derivative · entry 9

Gross Jane A · CIK 0001684258 · SVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,140

Underlying: Common Stock · 2,140 shares

Expires 2030-07-26

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F11 · derivative.exercise_date: These options will vest in three approximately equal annual installments beginning on the one year anniversary of the date of grant.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:50 UTC
Gross Jane ASVP & Chief Scientific Officer
GrantStock Option (right to buy) · Derivative 7,784 Not disclosed Strike: $8.56 Not disclosed
Disclosure

SEC source: 0001019056-20-000451 · gross.xml · derivative · entry 8

Gross Jane A · CIK 0001684258 · SVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,784

Underlying: Common Stock · 7,784 shares

Expires 2030-07-26

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F10 · derivative.exercise_date: These options vest in full on the one year anniversary of the date of grant.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:50 UTC
Gross Jane ASVP & Chief Scientific Officer
Disposition to issuerStock Option (right to buy) · Derivative 4,814 Not disclosed Strike: $21.28 Not disclosed
Disclosure

SEC source: 0001019056-20-000451 · gross.xml · derivative · entry 7

Gross Jane A · CIK 0001684258 · SVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,814 shares

Expires 2029-02-28

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F9 · derivative.exercise_date: This stock option award provides for vesting in three approximately equal annual installments beginning on February 28, 2020. Prior to July 27, 2020, all but 3,210 shares of the issuer's common stock underlying this stock option had vested.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:50 UTC
Gross Jane ASVP & Chief Scientific Officer
Disposition to issuerStock Option (right to buy) · Derivative 4,814 Not disclosed Strike: $43.82 Not disclosed
Disclosure

SEC source: 0001019056-20-000451 · gross.xml · derivative · entry 6

Gross Jane A · CIK 0001684258 · SVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,814 shares

Expires 2028-03-09

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F8 · derivative.exercise_date: This stock option award provides for vesting in three approximately equal annual installments beginning on March 9, 2019. Prior to July 27, 2020, all but 1,605 shares of the issuer's common stock underlying this stock option had vested.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:50 UTC
Gross Jane ASVP & Chief Scientific Officer
Disposition to issuerStock Option (right to buy) · Derivative 2,407 Not disclosed Strike: $30.10 Not disclosed
Disclosure

SEC source: 0001019056-20-000451 · gross.xml · derivative · entry 5

Gross Jane A · CIK 0001684258 · SVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,407 shares

Expires 2027-06-01

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F7 · derivative.exercise_date: This stock option award vested over three years, and the final one-third vested on June 1, 2020.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:50 UTC
Gross Jane ASVP & Chief Scientific Officer
Disposition to issuerStock Option (right to buy) · Derivative 2,407 Not disclosed Strike: $27.44 Not disclosed
Disclosure

SEC source: 0001019056-20-000451 · gross.xml · derivative · entry 4

Gross Jane A · CIK 0001684258 · SVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,407 shares

Expires 2027-02-24

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F6 · derivative.exercise_date: This stock option award vested over three years, and the final one-third vested on February 24, 2020.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:50 UTC
Gross Jane ASVP & Chief Scientific Officer
Disposition to issuerStock Option (right to buy) · Derivative 3,908 Not disclosed Strike: $41.58 Not disclosed
Disclosure

SEC source: 0001019056-20-000451 · gross.xml · derivative · entry 3

Gross Jane A · CIK 0001684258 · SVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,908 shares

Expires 2026-02-28

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F5 · derivative.exercise_date: This stock option award vested over three years, and the final one-third vested on March 1, 2019.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:50 UTC
Gross Jane ASVP & Chief Scientific Officer
Disposition to issuerStock Option (right to buy) · Derivative 2,779 Not disclosed Strike: $35.70 Not disclosed
Disclosure

SEC source: 0001019056-20-000451 · gross.xml · derivative · entry 2

Gross Jane A · CIK 0001684258 · SVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,779 shares

Expires 2022-03-09

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F4 · derivative.exercise_date: This stock option award vested on March 10, 2018. This award was originally part of a grant from Emergent dated March 11, 2015, of which two-thirds were vested at the time of conversion to the issuer's equity pool.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:50 UTC
Gross Jane ASVP & Chief Scientific Officer
Disposition to issuerStock Option (right to buy) · Derivative 2,072 Not disclosed Strike: $34.58 Not disclosed
Disclosure

SEC source: 0001019056-20-000451 · gross.xml · derivative · entry 1

Gross Jane A · CIK 0001684258 · SVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,072 shares

Expires 2021-03-10

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F2 · derivative.exercise_date: This stock option award vested on March 10, 2017. This award was originally part of a grant from Emergent BioSolutions Inc. ("Emergent") dated March 11, 2014, of which two-thirds were vested at the time of conversion to the issuer's equity pool.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 29, 2020 21:37 UTC
Maddux Randy JoeSVP of Operations, CMO
GrantStock Option (right to buy) · Derivative 2,140 Not disclosed Strike: $8.56 Not disclosed
Disclosure

SEC source: 0001019056-20-000439 · maddux.xml · derivative · entry 7

Maddux Randy Joe · CIK 0001683826 · SVP of Operations, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,140

Underlying: Common Stock · 2,140 shares

Expires 2030-07-26

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F9 · derivative.exercise_date: These options will vest in three approximately equal annual installments beginning on the one-year anniversary of the date of grant.

Read SEC document
July 27, 2020 Filed Jul 29, 2020 21:37 UTC
Maddux Randy JoeSVP of Operations, CMO
GrantStock Option (right to buy) · Derivative 6,423 Not disclosed Strike: $8.56 Not disclosed
Disclosure

SEC source: 0001019056-20-000439 · maddux.xml · derivative · entry 6

Maddux Randy Joe · CIK 0001683826 · SVP of Operations, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,423

Underlying: Common Stock · 6,423 shares

Expires 2030-07-26

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F8 · derivative.exercise_date: These options vest in full on the one year anniversary of the date of grant.

Read SEC document
July 27, 2020 Filed Jul 29, 2020 21:37 UTC
Maddux Randy JoeSVP of Operations, CMO
Disposition to issuerStock Option (right to buy) · Derivative 4,814 Not disclosed Strike: $21.28 Not disclosed
Disclosure

SEC source: 0001019056-20-000439 · maddux.xml · derivative · entry 5

Maddux Randy Joe · CIK 0001683826 · SVP of Operations, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,814 shares

Expires 2029-02-28

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F7 · derivative.exercise_date: These options provide for vesting in three approximately equal annual installments beginning on February 28. 2020. Prior to July 27, 2020, all but 3,210 shares of the issuer's common stock underlying this stock option had vested.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 29, 2020 21:37 UTC
Maddux Randy JoeSVP of Operations, CMO
Disposition to issuerStock Option (right to buy) · Derivative 4,814 Not disclosed Strike: $43.82 Not disclosed
Disclosure

SEC source: 0001019056-20-000439 · maddux.xml · derivative · entry 4

Maddux Randy Joe · CIK 0001683826 · SVP of Operations, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,814 shares

Expires 2028-03-09

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F6 · derivative.exercise_date: These options provide for vesting in three approximately equal annual installments beginning on March 9, 2018. Prior to July 27, 2020, all but 1,605 shares of the issuer's common stock underlying this stock option had vested.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 29, 2020 21:37 UTC
Maddux Randy JoeSVP of Operations, CMO
Disposition to issuerStock Option (right to buy) · Derivative 2,407 Not disclosed Strike: $30.10 Not disclosed
Disclosure

SEC source: 0001019056-20-000439 · maddux.xml · derivative · entry 3

Maddux Randy Joe · CIK 0001683826 · SVP of Operations, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,407 shares

Expires 2027-06-01

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F5 · derivative.exercise_date: This stock option award vested over three years, and the final one-third vested on June 1, 2020.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 29, 2020 21:37 UTC
Maddux Randy JoeSVP of Operations, CMO
Disposition to issuerStock Option (right to buy) · Derivative 2,407 Not disclosed Strike: $27.44 Not disclosed
Disclosure

SEC source: 0001019056-20-000439 · maddux.xml · derivative · entry 2

Maddux Randy Joe · CIK 0001683826 · SVP of Operations, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,407 shares

Expires 2027-02-24

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F4 · derivative.exercise_date: This stock option award vested over three years, and the final one-third vested on February 24, 2020.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 29, 2020 21:37 UTC
Maddux Randy JoeSVP of Operations, CMO
Disposition to issuerStock Option (right to buy) · Derivative 5,357 Not disclosed Strike: $41.16 Not disclosed
Disclosure

SEC source: 0001019056-20-000439 · maddux.xml · derivative · entry 1

Maddux Randy Joe · CIK 0001683826 · SVP of Operations, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,357 shares

Expires 2026-08-03

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F2 · derivative.exercise_date: This stock option award vested over three years, and the final one-third vested on August 3, 2020.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:51 UTC GrantStock Option (right to buy) · Derivative 2,140 Not disclosed Strike: $8.56 Not disclosed
Disclosure

SEC source: 0001019056-20-000454 · lamothe.xml · derivative · entry 9

Lamothe Jeffrey G. · CIK 0001679967 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,140

Underlying: Common Stock · 2,140 shares

Expires 2030-07-26

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F11 · derivative.exercise_date: These options will vest in three approximately equal annual installments beginning on the one year anniversary of the date of grant.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:51 UTC GrantStock Option (right to buy) · Derivative 7,380 Not disclosed Strike: $8.56 Not disclosed
Disclosure

SEC source: 0001019056-20-000454 · lamothe.xml · derivative · entry 8

Lamothe Jeffrey G. · CIK 0001679967 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,380

Underlying: Common Stock · 7,380 shares

Expires 2030-07-26

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F10 · derivative.exercise_date: These options vest in full on the one year anniversary of the date of grant.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:51 UTC Disposition to issuerStock Option (right to buy) · Derivative 4,814 Not disclosed Strike: $21.28 Not disclosed
Disclosure

SEC source: 0001019056-20-000454 · lamothe.xml · derivative · entry 7

Lamothe Jeffrey G. · CIK 0001679967 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,814 shares

Expires 2029-02-28

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F9 · derivative.exercise_date: This stock option award provides for vesting in three approximately equal annual installments beginning on February 28, 2020. Prior to July 27, 2020, all but 3,210 shares of the issuer's common stock underlying this stock option had vested.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:51 UTC Disposition to issuerStock Option (right to buy) · Derivative 4,814 Not disclosed Strike: $43.82 Not disclosed
Disclosure

SEC source: 0001019056-20-000454 · lamothe.xml · derivative · entry 6

Lamothe Jeffrey G. · CIK 0001679967 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,814 shares

Expires 2028-03-09

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F8 · derivative.exercise_date: This stock option award provides for vesting in three approximately equal annual installments beginning on March 9, 2019. Prior to July 27, 2020, all but 1,605 shares of the issuer's common stock underlying this stock option had vested.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:51 UTC Disposition to issuerStock Option (right to buy) · Derivative 2,407 Not disclosed Strike: $30.10 Not disclosed
Disclosure

SEC source: 0001019056-20-000454 · lamothe.xml · derivative · entry 5

Lamothe Jeffrey G. · CIK 0001679967 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,407 shares

Expires 2027-06-01

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F7 · derivative.exercise_date: This stock option award vested over three years, and the final one-third vested on June 1, 2020.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:51 UTC Disposition to issuerStock Option (right to buy) · Derivative 2,407 Not disclosed Strike: $27.44 Not disclosed
Disclosure

SEC source: 0001019056-20-000454 · lamothe.xml · derivative · entry 4

Lamothe Jeffrey G. · CIK 0001679967 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,407 shares

Expires 2027-02-24

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F6 · derivative.exercise_date: This stock option award vested over three years, and the final one-third vested on February 24, 2020.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:51 UTC Disposition to issuerStock Option (right to buy) · Derivative 3,128 Not disclosed Strike: $41.58 Not disclosed
Disclosure

SEC source: 0001019056-20-000454 · lamothe.xml · derivative · entry 3

Lamothe Jeffrey G. · CIK 0001679967 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,128 shares

Expires 2026-02-28

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F5 · derivative.exercise_date: This stock option award vested over three years, and the final one-third vested on March 1, 2019.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:51 UTC Disposition to issuerStock Option (right to buy) · Derivative 1,928 Not disclosed Strike: $35.70 Not disclosed
Disclosure

SEC source: 0001019056-20-000454 · lamothe.xml · derivative · entry 2

Lamothe Jeffrey G. · CIK 0001679967 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,928 shares

Expires 2022-03-09

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F4 · derivative.exercise_date: This stock option award vested in full on March 10, 2018. This award was originally part of a grant from Emergent dated March 11, 2015, of which two-thirds were vested at the time of conversion to the issuer's equity pool.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:51 UTC Disposition to issuerStock Option (right to buy) · Derivative 2,695 Not disclosed Strike: $34.58 Not disclosed
Disclosure

SEC source: 0001019056-20-000454 · lamothe.xml · derivative · entry 1

Lamothe Jeffrey G. · CIK 0001679967 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,695 shares

Expires 2021-03-10

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F2 · derivative.exercise_date: This stock option award vested on March 10, 2017. This award was originally part of a grant from Emergent BioSolutions Inc. ("Emergent") dated March 11, 2014, of which two-thirds were vested at the time of conversion to the issuer's equity pool.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:50 UTC GrantStock Option (right to buy) · Derivative 170 Not disclosed Strike: $8.56 Not disclosed
Disclosure

SEC source: 0001019056-20-000452 · harsanyi.xml · derivative · entry 5

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170

Underlying: Common Stock · 170 shares

Expires 2030-07-26

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F7 · derivative.exercise_date: These options will vest in three approximately equal annual installments beginning on the one year anniversary of the date of grant.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:50 UTC GrantStock Option (right to buy) · Derivative 1,322 Not disclosed Strike: $8.56 Not disclosed
Disclosure

SEC source: 0001019056-20-000452 · harsanyi.xml · derivative · entry 4

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,322

Underlying: Common Stock · 1,322 shares

Expires 2030-07-26

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F6 · derivative.exercise_date: These options vest in full on the one year anniversary of the date of grant.

Read SEC document
July 27, 2020 Filed Jul 31, 2020 20:50 UTC Disposition to issuerStock Option (right to buy) · Derivative 1,785 Not disclosed Strike: $76.86 Not disclosed
Disclosure

SEC source: 0001019056-20-000452 · harsanyi.xml · derivative · entry 3

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,785 shares

Expires 2028-06-01

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F5 · derivative.exercise_date: These options provide for vesting in three approximately equal annual installments beginning on May 31, 2019. Prior to July 27, 2020, all but 595 shares of the issuer's common stock underlying this stock option had vested.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.